BAT Cow's Milk for the Replacement of the Food Challenge Test
NCT ID: NCT05064917
Last Updated: 2022-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
700 participants
OBSERVATIONAL
2021-11-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: Determination of the (cost)effectiveness of the replacement of the expensive, risky and time-consuming food challenge test by the Basophil Activation Test (BAT) for the diagnosis of an IgE-mediated cow's milk allergy in children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Basophil Activation Test to Diagnose Food Allergy
NCT03309488
The Basophil Activation Test For Egg Allergy
NCT06559319
The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy
NCT03265262
Basophil Activation Test (BAT) Sensitivity in Child Food Allergy
NCT01966640
The Clinical Impact of the Basophil Activation Test to Diagnose Food Allergy
NCT05309772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with suspected cow's milk allergy
Blood draw
The burden for child/parents in this study is low as it is limited to a single blood draw, which is already necessary for usual diagnostic care in about 70% of the children
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood draw
The burden for child/parents in this study is low as it is limited to a single blood draw, which is already necessary for usual diagnostic care in about 70% of the children
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Suspected of cow's milk allergy with one or more of the following complaints after intake of cow's milk:
* angioedema
* urticaria
* sneezing and rhinitis \<2 hours after feeding
* sensation of swelling in the throat and/or difficulty swallowing \<2 hours after feeding
* voice change/hoarseness \<2 hours after feeding
* cough \<2 hours after feeding
* wheezing and/or shortness of breath \<2 hours after feeding
* loss of consciousness \<2 hours after feeding
* vomiting or abdominal pain or diarrhoea \<2 hours after feeding in children \<4 years only in combination with IgE-mediated complaints in other tracts
3. Placed on a waiting list for a hospital food challenge test
4. Blood draw for cow's milk sIgE and BAT \< 3 months before the food challenge test. This blood draw will be simultaneously scheduled with a blood draw for regular diagnostics.
5. Signed informed consent parents/guardians
Exclusion Criteria
2. Suspicion of Food Protein-Induced Enterocolitis Syndrome (FPIES)
3. Eosinophilic esophagitis due to a cow's milk allergy
4. Suspected cow's milk allergy \<4 years with crying and/or agitation and/or eczema and/or abdominal pain and/or failure to thrive and/or blood loss per anum and/or diarrhoea and/or reflux and/or vomiting as the only manifestation of the allergy without IgE-mediated symptoms in another organ system
5. Systemic immunosuppressant use
6. Other underlying chronic conditions (immunological, oncological, chromosomal abnormalities).
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alrijne Hospital
OTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Bernhoven Hospital
OTHER
Catharina Ziekenhuis Eindhoven
OTHER
Elkerliek Hospital
OTHER
Erasmus Medical Center
OTHER
Elisabeth-TweeSteden Ziekenhuis
OTHER
Maasstadziekenhuis
UNKNOWN
Meander Medisch Centrum
OTHER
OLVG
NETWORK
Spaarne Gasthuis
OTHER
Franciscus Gasthuis
OTHER
University Medical Center Groningen
OTHER
UMC Utrecht
OTHER
Viecurie Medisch Centrum voor Noord LImburg
UNKNOWN
Zuyderland Medisch Centrum
OTHER
Rijnstate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Janneke Ruinemans
Arnhem, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL76893.091.21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.